Masataka Hosoi
Overview
Explore the profile of Masataka Hosoi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
186
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hosoi M, Ueno K, Kikuchi J, Miyauchi J, Ooka R, Takikawa K, et al.
Int J Hematol
. 2024 Apr;
120(1):135-141.
PMID: 38634996
Gamma heavy chain disease (gHCD) is a rare B-cell lymphoproliferative disorder that mostly occurs after childbearing age. Here we report the first case of gHCD in a pregnant patient that...
2.
Kojima A, Hosoi M, Hayashi K, Fukumura M, Saga I
J Neuroendovasc Ther
. 2024 Feb;
18(2):47-52.
PMID: 38384392
Objective: We describe a patient with leukemia-related chronic subdural hematoma (CSDH) who was successfully treated using the combination of surgical evacuation and middle meningeal artery (MMA) embolization. Case Presentation: A...
3.
Matsukawa T, Yamamoto T, Honda A, Toya T, Ishiura H, Mitsui J, et al.
Brain Commun
. 2020 Sep;
2(1):fcz048.
PMID: 32954314
Accumulated experience supports the efficacy of allogenic haematopoietic stem cell transplantation in arresting the progression of childhood-onset cerebral form of adrenoleukodystrophy in early stages. For adulthood-onset cerebral form of adrenoleukodystrophy,...
4.
Taoka K, Arai S, Kataoka K, Hosoi M, Miyauchi M, Yamazaki S, et al.
Sci Rep
. 2018 Oct;
8(1):15855.
PMID: 30367142
Chronic myelomonocytic leukemia (CMML) is an entity of myelodysplastic syndrome/myeloproliferative neoplasm. Although CMML can be cured with allogeneic stem cell transplantation, its prognosis is generally very poor due to the...
5.
Hosoi M, Kumano K, Taoka K, Arai S, Kataoka K, Ueda K, et al.
Exp Hematol
. 2014 May;
42(9):816-25.
PMID: 24859480
Induced pluripotent stem cells (iPS) derived from disease cells are expected to provide a new experimental material, especially for diseases from which samples are difficult to obtain. In this study,...
6.
Furuta T, Kiryu S, Yamada H, Hosoi M, Kurokawa M, Morikawa T, et al.
Jpn J Radiol
. 2014 Feb;
32(5):282-7.
PMID: 24531980
Erdheim-Chester disease (ECD) is a non-Langerhans cell histiocytosis. Herein we report a case of a 49-year-old woman who developed bilateral knee pain. Imaging procedures revealed multiple long bone lesions and...
7.
Kumano K, Arai S, Hosoi M, Taoka K, Takayama N, Otsu M, et al.
Blood
. 2012 May;
119(26):6234-42.
PMID: 22592606
Induced pluripotent stem cells (iPSCs) can be generated by the expression of defined transcription factors not only from normal tissue, but also from malignant cells. Cancer-derived iPSCs are expected to...
8.
Nakazaki K, Hosoi M, Hangaishi A, Ichikawa M, Nannya Y, Kurokawa M
Intern Med
. 2012 Apr;
51(8):859-63.
PMID: 22504239
Objective: Recently, pulsed high-dose dexamethasone (HD-Dexa) therapy was proposed as a possible alteration for the classical prednisolone (PSL) therapy for primary immune thrombocytopenia (ITP) patients, however it remains to be...
9.
Taoka K, Kumano K, Nakamura F, Hosoi M, Goyama S, Imai Y, et al.
Int J Hematol
. 2011 Dec;
95(2):149-59.
PMID: 22193844
We investigated the mechanisms of hematopoietic disorders caused by iron overload and chelation, in particular, the inhibition of erythroblast differentiation. Murine c-kit(+) progenitor cells or human CD34(+) peripheral blood hematopoietic...
10.
Yamamoto G, Hosoi M, Miyagawa T, Ohmatsu H, Ichikawa M, Sugaya M, et al.
Ann Hematol
. 2011 Mar;
91(1):123-4.
PMID: 21437588
No abstract available.